In 2024, Eli Lilly and Co completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Eli Lilly and Co has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2024, the total operational greenhouse gas (GHG) emissions of Eli Lilly and Co amounted to 450,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Eli Lilly and Co decreased by 14.61%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
In 2024, the total Scope 1 emissions of Eli Lilly and Co were 192,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Since 2018, Eli Lilly and Co's Scope 1 emissions have decreased by 4.48%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), Eli Lilly and Co's Scope 1 emissions increased by 5.49%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
In 2024, Eli Lilly and Co reported Scope 2 greenhouse gas (GHG) emissions of 258,000 tCOâ‚‚e using the market-based method.
Compared to the previous year (2023), Eli Lilly and Co's Scope 2 emissions (Market-Based) fell by 25.22% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
In 2024, Eli Lilly and Co reported its Scope 2 emissions using the market-based method.